Menu

A. Gadisseur MD, PhD

Articles

P03 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN A BELGIAN SURVEY

BJH - 2019, issue ?, february 2019

I. Vangenechten , J. Jongenotter , K. Jochmans MD, PhD, C. Orlando , A. Gothot MD, PhD, K. Vandenbosch , A. Gadisseur MD, PhD

Read more

P04 DIFFERENCES IN FVIII MEASUREMENTS OF PLASMA SPIKED WITH AFSTYLA GENERATED WITH ONE-STAGE CLOTTING ASSAY USING DIFFERENT COMMERCIAL APTT REAGENTS COMPARED WITH CHROMOGENIC METHOD

BJH - 2019, issue ?, february 2019

I. Vangenechten , M. Maes PhD, PharmD, A. Gadisseur MD, PhD

Read more

P05 DIFFERENCES IN ACTIVITY OF PLASMA SPIKED WITH IDELVION GENERATED WITH ONE-STAGE CLOTTING ASSAY USING DIFFERENT COMMERCIAL APTT REAGENTS COMPARED WITH CHROMOGENIC METHOD

BJH - 2019, issue ?, february 2019

I. Vangenechten , M. Maes PhD, PharmD, A. Gadisseur MD, PhD

Read more

P06 EVALUATION OF VON WILLEBRAND FACTOR MULTIMER DISTRIBUTION USING A NEW SEMI-AUTOMATED VON WILLEBRAND MULTIMERIC ASSAY, HYDRAGEL VW MULTIMER (SEBIA)

BJH - 2019, issue ?, february 2019

I. Vangenechten , A. Gadisseur MD, PhD

Read more

P07 EVALUATION OF AN AUTOMATED VON WILLEBRAND FACTOR COLLAGEN BINDING ASSAY, HEMOSIL® ACUSTAR® VWF:CB

BJH - 2019, issue ?, february 2019

I. Vangenechten , M. Maes PhD, PharmD, A. Gadisseur MD, PhD

Read more

P35 PD-1 blockade in a patient with relapsed Hodgkin lymphoma post-allogeneic hematopoietic cell transplant: complete metabolic response without graft-versus-host-disease

BJH - 2018, issue Abstract Book BHS, february 2018

K. Saevels MD, A. Van de Velde MD, S. Anguille MD, PhD, A. Verlinden MD, A. Gadisseur MD, PhD, W. Schroyens MD, PhD, Z. Berneman MD, PhD

Read more

A-128 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN BELGIUM

BJH - volume 8, issue Abstract Book BSTH, february 2017

J. Jongenotter , I. Vangenechten , K. Jochmans MD, PhD, C. Orlando , A. Gothot MD, PhD, K. Vandenbosch , A. Gadisseur MD, PhD

Read more
Top